Abiopharma

🔍 Kuczinski Anthony J (Executive)

Company: Skyward Specialty Insurance Group, Inc. (SKWD)

Report Date: 2026-05-06

Detailed Transactions and Holdings:

• Acquired 1,797 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 13,977.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 3,334 shares of 2026 RSU Award (Derivative)
  Date: 2026-05-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,334.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
• Sold 1,797 shares of 2025 RSU Award (Derivative)
  Date: 2026-05-07 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F4, F4

Footnotes:

• F1: Each Restricted Stock Unit ("RSU") settles for one share of the Issuer's Common Stock.
• F2: Each RSU represents the right to receive, after vesting and upon settlement, one share of Common Stock of the Issuer.
• F3: On May 6, 2026, the Reporting Person was granted an RSU Award in the amount of 3,334 RSUs. Subject to the terms of the award agreement, this award will fully vest on the date of the Issuer's 2027 Annual Meeting of Shareholders.
• F4: On May 7, 2025, the Reporting Person was granted an RSU Award in the amount of 1,797 RSUs. Subject to the terms of the RSU Agreement, this award fully vested on May 7, 2026.